A combination of circulating tumor cells and CA199 improves the diagnosis of pancreatic cancer
{{output}}
Background: Early diagnosis of pancreatic ductal adenocarcinoma (PDAC) is difficult due to the lack of effective screening tests. CA199, the standard biomarker for PDAC management, is not sufficiently reliable for early diagnosis... ...
